Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Publikationen

Suchbegriffe: ADENOCARCINOMA - DRUG THERAPY , . Treffer: 27

2018

Rogatsch, M; Schmid, J; Lax, S; Uranitsch, M; Schmid-Zalaudek, K; Giuffrida, R; Zalaudek, I Metastatic cutaneous apocrine adenocarcinoma responsive to the programmed cell death protein 1 inhibitor pembrolizumab.
Eur J Cancer. 2018; 90:146-148 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

Smith, MR; Saad, F; Chowdhury, S; Oudard, S; Hadaschik, BA; Graff, JN; Olmos, D; Mainwaring, PN; Lee, JY; Uemura, H; Lopez-Gitlitz, A; Trudel, GC; Espina, BM; Shu, Y; Park, YC; Rackoff, WR; Yu, MK; Small, EJ; SPARTAN Investigators Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer.
N Engl J Med. 2018; 378(15): 1408-1418. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2016

Bonin, S; Donada, M; Bussolati, G; Nardon, E; Annaratone, L; Pichler, M; Chiaravalli, AM; Capella, C; Hoefler, G; Stanta, G A synonymous EGFR polymorphism predicting responsiveness to anti-EGFR therapy in metastatic colorectal cancer patients.
Tumour Biol. 2016; 37(6):7295-7303
Web of Science PubMed FullText FullText_MUG

 

Grillo, F; Fassan, M; Sarocchi, F; Fiocca, R; Mastracci, L HER2 heterogeneity in gastric/gastroesophageal cancers: From benchside to practice.
World J Gastroenterol. 2016; 22(26):5879-5887 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Jagadeeshan, S; Subramanian, A; Tentu, S; Beesetti, S; Singhal, M; Raghavan, S; Surabhi, RP; Mavuluri, J; Bhoopalan, H; Biswal, J; Pitani, RS; Chidambaram, S; Sundaram, S; Malathi, R; Jeyaraman, J; Nair, AS; Venkatraman, G; Rayala, SK P21-activated kinase 1 (Pak1) signaling influences therapeutic outcome in pancreatic cancer.
Ann Oncol. 2016; 27(8):1546-1556
Web of Science PubMed FullText FullText_MUG

 

Perakis, SO; Thomas, JE; Pichler, M Non-coding RNAs Enabling Prognostic Stratification and Prediction of Therapeutic Response in Colorectal Cancer Patients.
Adv Exp Med Biol. 2016; 937(4):183-204
Web of Science PubMed FullText FullText_MUG

 

2015

Grabner, B; Schramek, D; Mueller, KM; Moll, HP; Svinka, J; Hoffmann, T; Bauer, E; Blaas, L; Hruschka, N; Zboray, K; Stiedl, P; Nivarthi, H; Bogner, E; Gruber, W; Mohr, T; Zwick, RH; Kenner, L; Poli, V; Aberger, F; Stoiber, D; Egger, G; Esterbauer, H; Zuber, J; Moriggl, R; Eferl, R; Győrffy, B; Penninger, JM; Popper, H; Casanova, E Disruption of STAT3 signalling promotes KRAS-induced lung tumorigenesis.
Nat Commun. 2015; 6(4):6285-6285 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Obenauf, AC; Zou, Y; Ji, AL; Vanharanta, S; Shu, W; Shi, H; Kong, X; Bosenberg, MC; Wiesner, T; Rosen, N; Lo, RS; Massagué, J Therapy-induced tumour secretomes promote resistance and tumour progression.
Nature. 2015; 520(7547): 368-372. [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Tsao, MS; Marguet, S; Le Teuff, G; Lantuejoul, S; Shepherd, FA; Seymour, L; Kratzke, R; Graziano, SL; Popper, HH; Rosell, R; Douillard, JY; Le-Chevalier, T; Pignon, JP; Soria, JC; Brambilla, EM Subtype Classification of Lung Adenocarcinoma Predicts Benefit From Adjuvant Chemotherapy in Patients Undergoing Complete Resection.
J Clin Oncol. 2015; 33(30):3439-3446 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Volgger, B; Zeimet, AG; Reinthaller, A; Petru, E; Schauer, C; Klein, M; Sevelda-Schwarzgruber, U; Bogner, G; Wolfram, G; Marth, C Carboplatin and nonpegylated liposomal doxorubicin in primary advanced or recurrent endometrial cancer: a phase 2 trial conducted by AGO Austria.
Int J Gynecol Cancer. 2015; 25(2):257-262 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2014

Cota, C; Lora, V; Facchetti, F; Cerroni, L Localized post-radiation Kaposi sarcoma in a renal transplant immunosuppressed patient.
Am J Dermatopathol. 2014; 36(3):270-273 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

Forster, T; Rausch, V; Zhang, Y; Isayev, O; Heilmann, K; Schoensiegel, F; Liu, L; Nessling, M; Richter, K; Labsch, S; Nwaeburu, CC; Mattern, J; Gladkich, J; Giese, N; Werner, J; Schemmer, P; Gross, W; Gebhard, MM; Gerhauser, C; Schaefer, M; Herr, I Sulforaphane counteracts aggressiveness of pancreatic cancer driven by dysregulated Cx43-mediated gap junctional intercellular communication.
Oncotarget. 2014; 5(6):1621-1634 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Fröhlich, E; Wahl, R The current role of targeted therapies to induce radioiodine uptake in thyroid cancer.
CANCER TREAT REV. 2014; 40(5): 665-674.
Web of Science PubMed FullText FullText_MUG

 

Ress, AL; Stiegelbauer, V; Schwarzenbacher, D; Deutsch, A; Perakis, S; Ling, H; Ivan, C; Calin, GA; Rinner, B; Gerger, A; Pichler, M Spinophilin expression determines cellular growth, cancer stemness and 5-flourouracil resistance in colorectal cancer.
Oncotarget. 2014; 5(18):8492-8502 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2011

Ofner, D; Devries, AF; Schaberl-Moser, R; Greil, R; Rabl, H; Tschmelitsch, J; Zitt, M; Kapp, KS; Fastner, G; Keil, F; Eisterer, W; Jäger, R; Offner, F; Gnant, M; Thaler, J; TAKO 05/ABCSG R-02 Trial Investigators Preoperative oxaliplatin, capecitabine, and external beam radiotherapy in patients with newly diagnosed, primary operable, cT₃NxM0, low rectal cancer: a phase II study.
Strahlenther Onkol. 2011; 187(2):100-107
Web of Science PubMed FullText FullText_MUG

 

Popper, H; Wrba, F; Gruber-Mösenbacher, U; Hulla, W; Pirker, R; Hilbe, W; Studnicka, M; Mohn-Staudner, A; Ploner, F; und die Arbeitsgruppe Pulmopathologie der ÖGP-IAP Histology-based algorithm in the molecular diagnosis of mutations of the Epidernal Growth Factor Receptor (EGFR) in non-small cell lung cancer.
Wien Klin Wochenschr. 2011; 123(9-10):316-321
Web of Science PubMed FullText FullText_MUG

 

2010

Hoffmann, K; Franz, C; Hinz, U; Schirmacher, P; Herfarth, C; Eichbaum, M; Büchler, MW; Schemmer, P Liver resection for multimodal treatment of breast cancer metastases: identification of prognostic factors.
Ann Surg Oncol. 2010; 17(6):1546-1554
Web of Science PubMed FullText FullText_MUG

 

2007

Schippinger, W; Samonigg, H; Schaberl-Moser, R; Greil, R; Thödtmann, R; Tschmelitsch, J; Jagoditsch, M; Steger, GG; Jakesz, R; Herbst, F; Hofbauer, F; Rabl, H; Wohlmuth, P; Gnant, M; Thaler, J; Austrian Breast and Colorectal Cancer Study Group A prospective randomised phase III trial of adjuvant chemotherapy with 5-fluorouracil and leucovorin in patients with stage II colon cancer.
BRIT J CANCER. 2007; 97(8): 1021-1027. [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG Google Scholar

 

2001

Maier, A; Tomaselli, F; Matzi, V; Rehak, P; Pinter, H; Smolle-Jüttner, FM Does new photosensitizer improve photodynamic therapy in advanced esophageal carcinoma?
Lasers Surg Med. 2001; 29(4):323-327
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Maier, A; Tomaselli, F; Matzi, V; Rehak, P; Pinter, H; Smolle-Jüttner, FM Photosensitization with hematoporphyrin derivative compared to 5-aminolaevulinic acid for photodynamic therapy of esophageal carcinoma.
Ann Thorac Surg. 2001; 72(4):1136-1140
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Zotter, H; Schwinger, W; Kerbl, R; Urban, C; Smolle Juettner, FM; Hinterleitner, T Management of a 16-year-old boy with adenocarcinoma at the esophageal gastric junction.
Med Pediatr Oncol. 2001; 37(6):557-557 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

2000

Maier, A; Anegg, U; Tomaselli, F; Rehak, P; Sankin, O; Fell, B; Renner, H; Pinter, H; Smolle-Jüttner, FM; Friehs, GB Does hyperbaric oxygen enhance the effect of photodynamic therapy in patients with advanced esophageal carcinoma? A clinical pilot study.
Endoscopy. 2000; 32(1):42-48
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Maier, A; Tomaselli, F; Gebhard, F; Rehak, P; Smolle, J; Smolle-Jüttner, FM Palliation of advanced esophageal carcinoma by photodynamic therapy and irradiation.
Ann Thorac Surg. 2000; 69(4):1006-1009
Web of Science PubMed FullText FullText_MUG Google Scholar

 

1996

Cunningham, D; Zalcberg, JR; Rath, U; Oliver, I; van Cutsem, E; Svensson, C; Seitz, JF; Harper, P; Kerr, D; Perez-Manga, G Final results of a randomised trial comparing 'Tomudex' (raltitrexed) with 5-fluorouracil plus leucovorin in advanced colorectal cancer. Tomudex Colorectal Cancer Study Group.
Ann Oncol. 1996; 7(9):961-965 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

1990

Pakisch, B; Poschauko, J; Stücklschweiger, G; Poier, E; Lahousen, M; Pickel, H; Kohek, P; Klug, P; Hackl, A Treatment of primary cancer of the fallopian tube
GEBURTSH FRAUENHEILK. 1990; 50(8): 593-596.
Web of Science PubMed FullText FullText_MUG Google Scholar

 

1989

Langsteger, W; Lind, P; Beham, A; Klima, G; Eber, B; Költringer, P; Eber, O Metastatic thyroid cancer: sudden death following aclarubicin therapy
Klin Wochenschr. 1989; 67(7):393-397 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

1988

Lahousen, M; Pickel, H Adjuvant gestagen therapy in stage I endometrial cancer
ZBL GYNAKOL. 1988; 110(16): 1013-1017.
Web of Science PubMed Google Scholar

 

© Med Uni Graz Impressum